CLINICAL_TRIALS
trial_result
· 2015-03-13
Clinical Trial Update: 13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants. [Phase 3]
Summary
Phase 3 trial evaluating safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine in healthy infants; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pneumococcal Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2015-03-13